Stock Research: Apollo Hospitals Enterprise

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Apollo Hospitals Enterprise

NSI:APOLLOHOSP INE437A01024
52
  • Value
    11
  • Growth
    87
  • Safety
    Safety
    25
  • Combined
    21
  • Sentiment
    72
  • 360° View
    360° View
    52
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Apollo Hospitals Enterprise Limited is an integrated healthcare company providing hospital services, pharmacy sales, and wellness products. It operates in Healthcare Services, Retail Health and Diagnostics (clinics and diagnostics), Digital Health and Pharmacy Distribution (pharmaceuticals, FMCG, private label products via digital platform), and Others. The company has approximately 10,000+ beds across 73 hospitals, 5000+ pharmacies, 378+ clinics and diagnostic centers, and 200 telemedicine centers. In the last fiscal year, the company had a market cap of $12298 million, profits of $1227 million, and revenue of $2550 million.

more
Index
CNX Nifty 50
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
11 17 8 11
Growth
87 91 87 95
Safety
Safety
25 14 24 12
Sentiment
72 55 82 59
360° View
360° View
52 31 48 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
96 81 82 87
Opinions Change
48 33 54 50
Pro Holdings
n/a 32 42 12
Market Pulse
64 84 74 55
Sentiment
72 55 82 59
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
11 17 8 11
Growth
87 91 87 95
Safety Safety
25 14 24 12
Combined
21 20 23 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
20 39 42 36
Price vs. Earnings (P/E)
12 13 5 7
Price vs. Book (P/B)
1 5 5 9
Dividend Yield
32 28 24 25
Value
11 17 8 11
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
100 83 87 70
Profit Growth
86 73 61 98
Capital Growth
18 93 98 36
Stock Returns
69 41 51 97
Growth
87 91 87 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
18 20 28 14
Refinancing
36 17 21 25
Liquidity
39 51 46 25
Safety Safety
25 14 24 12

Similar Stocks

Discover high‑ranked alternatives to Apollo Hospitals Enterprise and broaden your portfolio horizons.

SBI Life Insurance

NSI:SBILIFE
Country: India
Industry: Life & Health Insurance
Size: Medium
Full Stock Analysis

Canara Bank

NSI:CANBK
Country: India
Industry: Diversified Banks
Size: Medium
Full Stock Analysis

Oil and Natural Gas

NSI:ONGC
Country: India
Industry: Oil & Gas Integrated
Size: XX-Large
Full Stock Analysis

Gail

NSI:GAIL
Country: India
Industry: Gas Utilities
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a classic, high-risk growth play: high growth and positive sentiment outweigh low Value Rank (expensive) and risky financing. This is for aggressive growth investors who are comfortable with the high price and risk, believing the growth story justifies the expense.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: